Farkhondeh, T.; Amirabadizadeh, A.; Aramjoo, H.; Llorens, S.; Roshanravan, B.; Saeedi, F.; Talebi, M.; Shakibaei, M.; Samarghandian, S.
Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials. Curr. Oncol. 2021, 28, 1412-1423.
https://doi.org/10.3390/curroncol28020134
AMA Style
Farkhondeh T, Amirabadizadeh A, Aramjoo H, Llorens S, Roshanravan B, Saeedi F, Talebi M, Shakibaei M, Samarghandian S.
Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials. Current Oncology. 2021; 28(2):1412-1423.
https://doi.org/10.3390/curroncol28020134
Chicago/Turabian Style
Farkhondeh, Tahereh, Alireza Amirabadizadeh, Hamed Aramjoo, Silvia Llorens, Babak Roshanravan, Farhad Saeedi, Marjan Talebi, Mehdi Shakibaei, and Saeed Samarghandian.
2021. "Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials" Current Oncology 28, no. 2: 1412-1423.
https://doi.org/10.3390/curroncol28020134
APA Style
Farkhondeh, T., Amirabadizadeh, A., Aramjoo, H., Llorens, S., Roshanravan, B., Saeedi, F., Talebi, M., Shakibaei, M., & Samarghandian, S.
(2021). Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials. Current Oncology, 28(2), 1412-1423.
https://doi.org/10.3390/curroncol28020134